Karin Karlsson (Former)
1 – 23 of 23
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2020
-
Mark
Introducing patient-reported outcome in the acute leukemia quality registries in Sweden
(
- Contribution to journal › Article
- 2017
-
Mark
Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden
(
- Contribution to journal › Article
- 2016
-
Mark
Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia : Data from 95 consecutive patients treated in a compassionate use program. A study from the swedish chronic lymphocytic leukemia group
(
- Contribution to journal › Article
- 2015
-
Mark
Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study
(
- Contribution to journal › Article
- 2014
-
Mark
Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study
(
- Contribution to journal › Article
-
Mark
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic
(
- Contribution to journal › Article
-
Mark
High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007
(
- Contribution to journal › Article
- 2011
-
Mark
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006.
(
- Contribution to journal › Article
-
Mark
t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens.
(
- Contribution to journal › Letter
- 2010
-
Mark
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
MDM2 SNP309 promoter polymorphism, an independent prognostic factor in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Population-based analyses in adult acute lymphoblastic leukemia
(
- Contribution to journal › Letter
- 2009
-
Mark
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: A high-resolution genomic screening in newly diagnosed patients
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0354-0354(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
The BCL-2 promoter (-938C > A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Inferior Overall Survival In Cll Patients With Tp53 Mutations And Mdm2 Snp309 Polymorphism
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0529-0529(
- Contribution to journal › Published meeting abstract
-
Mark
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
(
- Contribution to journal › Article
-
Mark
The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
An investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia : a multi-center study of 381 patients
(
- Contribution to journal › Article
- 2006
-
Mark
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
(
- Contribution to journal › Article
- 2005
-
Mark
Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience
(
- Contribution to journal › Article